Characterization of volumetric growth of intracranial meningiomas in Māori and Pasifika populations in New Zealand

Māori and Pasifika populations in New Zealand have a higher incidence and prevalence of intracranial meningioma (IM). We sought to evaluate the volumetric growth rate of meningiomas under surveillance in these populations.

[1]  M. Dragunow,et al.  The epidemiology of patients undergoing meningioma resection in Auckland, New Zealand, 2002 to 2011 , 2020, Journal of Clinical Neuroscience.

[2]  S. Nakasu,et al.  Natural History of Meningiomas: Review with Meta-analyses , 2020, Neurologia medico-chirurgica.

[3]  G. Eide,et al.  A prospective study of the natural history of incidental meningioma-Hold your horses! , 2019, Neuro-oncology practice.

[4]  N. Srikandarajah,et al.  Incidental intracranial meningiomas: a systematic review and meta-analysis of prognostic factors and outcomes , 2019, Journal of Neuro-Oncology.

[5]  Jill S Barnholtz-Sloan,et al.  CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2011-2015. , 2018, Neuro-oncology.

[6]  S. Nakasu,et al.  P05.22 Growth deceleration of meningioma associates with progression of calcification: evaluation with CT Hounsfields units , 2018, Neuro-Oncology.

[7]  U. Bogdahn,et al.  Diabetes, use of metformin, and the risk of meningioma , 2017, PloS one.

[8]  H. Duffau,et al.  Epidemiology for primary brain tumors: a nationwide population-based study , 2017, Journal of Neuro-Oncology.

[9]  Young-Hoon Kim,et al.  A novel weighted scoring system for estimating the risk of rapid growth in untreated intracranial meningiomas. , 2017, Journal of neurosurgery.

[10]  A. Ahlbom,et al.  Association between prediagnostic glucose, triglycerides, cholesterol and meningioma, and reverse causality , 2016, British Journal of Cancer.

[11]  R. Ali,et al.  Nervous System and Intracranial Tumour Incidence by Ethnicity in England, 2001–2007: A Descriptive Epidemiological Study , 2016, PloS one.

[12]  V. Beral,et al.  Menopausal hormone therapy and central nervous system tumor risk: Large UK prospective study and meta‐analysis , 2015, International journal of cancer.

[13]  Z. Qi,et al.  Overweight, Obesity and Meningioma Risk: A Meta-Analysis , 2014, PloS one.

[14]  M. Wrensch,et al.  Exogenous hormone use, reproductive factors, and risk of intracranial meningioma in females. , 2013, Journal of neurosurgery.

[15]  H. Kishima,et al.  Slower growth of skull base meningiomas compared with non-skull base meningiomas based on volumetric and biological studies. , 2012, Journal of Neurosurgery.

[16]  S. Oya,et al.  The natural history of intracranial meningiomas. , 2011, Journal of neurosurgery.

[17]  J. Jito,et al.  Growth curve analysis of asymptomatic and symptomatic meningiomas , 2011, Journal of Neuro-Oncology.

[18]  A. Auvinen,et al.  Female predominance in meningiomas can not be explained by differences in progesterone, estrogen, or androgen receptor expression , 2006, Journal of Neuro-Oncology.

[19]  Sarah Olson,et al.  Meningiomas and the Polynesian population , 2005, ANZ journal of surgery.

[20]  Madjid Samii,et al.  The Natural History of Incidental Meningiomas , 2003, Neurosurgery.